Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02805062
Other study ID # GN16ON124
Secondary ID
Status Not yet recruiting
Phase N/A
First received June 15, 2016
Last updated June 20, 2016
Start date June 2016
Est. completion date July 2017

Study information

Verified date June 2016
Source NHS Greater Glasgow and Clyde
Contact Paul Dearie, BSc (HONS)
Phone +44 (0)141 232 1810
Email paul.dearie@ggc.scot.nhs.uk
Is FDA regulated No
Health authority Scotland: Scottish Executive Health Department
Study type Observational

Clinical Trial Summary

Malignant pleural effusion is a common clinical problem with median survival of approximately 6 months thus efficient management of Malignant pleural effusion is important. In patients with a Trapped Lung, pleurodesis will be unsuccessful and an indwelling pleural catheter should be inserted instead. Accurate detection of Trapped Lung prior to insertion would avoid futile attempts at talc pleurodesis, re-intervention following failed pleurodesis and allow adequate time to plan for an indwelling pleural catheter insertion.Pleural manometry allows direct and objective measurement of intra-pleural pressure during pleural fluid aspiration.The primary aim of this study is to determine whether the addition of digital pleural manometry to clinical judgment, prior to and during local anaesthetic thoracoscopy, results in a clinically meaningful improvement in Trapped Lung detection.


Description:

Malignant pleural effusion is a common clinical problem with median survival of approximately 6 months. Efficient management of Malignant pleural effusion is therefore a major priority for patients, for whom failed procedures and the need for repeat hospital admissions limits their time at home with family and friends.

The management of Malignant pleural effusion involves either complete pleural fluid drainage followed by some form of pleurodesis or insertion of an indwelling pleural catheter. Apposition of the parietal and visceral pleural surfaces is a pre-requisite for successful pleurodesis. In patients with a non-expansile, or Trapped Lung, pleurodesis will be unsuccessful and an indwelling pleural catheter should be inserted instead. Accurate detection of Trapped Lung prior to insertion would avoid futile attempts at talc pleurodesis, re-intervention following failed pleurodesis and allow adequate time to plan for an indwelling pleural catheter insertion, including training of the patient's District Nurses. Clinical judgment is currently used to detect Trapped Lung. This involves review of available imaging and direct visualisation of the surface of the lung during local anaesthetic thoracoscopy. Unfortunately, recent data suggest this is frequently inaccurate, with 30% and 13% of cases of Trapped Lung correctly identified in recent local and national audit data respectively.

Pleural manometry allows direct and objective measurement of intra-pleural pressure during pleural fluid aspiration. Pleural pressure measurements can also be used to compute Pleural Elastance, defined as change in pleural pressure divided by change in pleural volume. Previous studies have shown that a rapid and sustained drop in intra-pleural pressure during fluid aspiration can predict Trapped Lung but these data have not been prospectively compared with current clinical practice.

The primary aim of this study is to determine whether the addition of digital pleural manometry to clinical judgment, prior to and during local anaesthetic thoracoscopy, results in a clinically meaningful improvement in Trapped Lung detection. Digital pleural manometry will be recorded using a Conformité Européene marked (CE-marked) device used within its existing clinical indication (developed in conjunction with our commercial partner Rocket Medical plc).

65 Subjects will have a single study visit, which will coincide with their planned clinical admission for local anaesthetic thoracoscopy. Subjects will exit the study after a follow-up clinic visit 3 months after the date of local anaesthetic thoracoscopy. A study-specific volumetric Magnetic Resonance Imaging scan of the pleural cavity will be performed as per pre-defined imaging protocols.

The study will be performed at a single centre: Queen Elizabeth University Hospital, Glasgow.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 65
Est. completion date July 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Informed written consent

- Suspected pleural malignancy requiring investigation by local anaesthetic thoracoscopy

Exclusion Criteria:

- Any contra-indication to local anaesthetic thoracoscopy

- Predicted pleural aspiration volume < 1 litre, as defined by a maximum pleural fluid depth of < 4 cm on thoracic ultrasound pre-aspiration

- Known contra-indication to MRI

- Previous attempt at talc pleurodesis

- Pregnancy

- • Renal impairment (eGFR = 30 ml/min)

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Digital Pleural Manometry
Measurement of intra-pleural pressure and the removal of pleural fluid.
Magnetic Resonance Imaging
Subject lies a long tunnel shaped scanner and images are recorded.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
NHS Greater Glasgow and Clyde Rocket Medical plc

Outcome

Type Measure Description Time frame Safety issue
Primary Pleural Elastance Pleural elastance (change in pleural pressure divided by change in pleural volume), where trapped lung will be predicted by pleural elastance = 14.5 cm pleural pressure. Single visit per subject No
Primary Clinical judgement The clinical judgment of the Thoracoscopist as to the presence or absence of Trapped Lung Single visit per subject No
Primary Trapped Lung Occurrence of trapped lung, defined as incomplete lung re-expansion on the pre-discharge chest radiograph after local anaesthetic thoracoscopy Single visit per subject No
Secondary PEL-VOUT Agreement level of agreement between Indirect Pleural Elastance (PEL) computed using pleural fluid output (VOUT) and Direct PEL, computing using directly measured pleural cavity volume by MRI. Single visit per subject No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05693727 - Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion
Recruiting NCT05910112 - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Completed NCT03270215 - The Added Value of CT Scanning in Patients With an Unilateral Pleural Effusion
Completed NCT03272997 - The Value of PET-CT in Pleural Effusions
Completed NCT00099541 - Non-small Cell Lung Cancer Registry Phase 4
Recruiting NCT04844827 - Pleural Carcinomatosis Tissue Banking
Not yet recruiting NCT06436807 - PMCF Study of the CE-marked Drainova® ArgentiC Catheter
Recruiting NCT05278975 - Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma Phase 1/Phase 2
Recruiting NCT02407912 - Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer N/A
Terminated NCT00316134 - Multiple Biomarkers in Undiagnosed Pleural Effusion N/A
Not yet recruiting NCT06275178 - Medical Thoracoscopy for Diagnosing Unexplained Pleural Effusion: a National Multicenter Retrospective Study
Recruiting NCT04684459 - Dual-targeting HER2 and PD-L1 CAR-T for Cancers With Pleural or Peritoneal Metastasis Early Phase 1
Recruiting NCT04670562 - Longitudinal Follow up of Patients With Pleural Effusion
Completed NCT03276715 - Prognostic Factors on Malignant Pleural Effusion
Completed NCT03394105 - Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer Phase 2
Recruiting NCT05461430 - Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Terminated NCT02702700 - Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies Phase 1
Recruiting NCT02045121 - Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis for Malignant Pleural Effusion Management N/A
Completed NCT01670786 - Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion Phase 4
Active, not recruiting NCT05077111 - A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia Phase 4